| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/22/2009 | CA2705947A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | CA2705708A1 Methods for treating obesity and obesity related diseases and disorders |
| 05/22/2009 | CA2705502A1 Phenylpyrazole derivatives |
| 05/22/2009 | CA2705370A1 Heteroaryloxy quinazoline derivatives |
| 05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | CA2704074A1 Novel methyl-benzimidazole derivatives |
| 05/21/2009 | US20090131946 Devices and Methods for the Restoration of a Spinal Disc |
| 05/21/2009 | US20090131520 Lipid metabolism Improving Composition |
| 05/21/2009 | US20090131515 Combination of antidiabetic drugs |
| 05/21/2009 | US20090131507 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases |
| 05/21/2009 | US20090131497 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 05/21/2009 | US20090131492 Indole derivatives as CFTR modulators |
| 05/21/2009 | US20090131491 ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11(beta)-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/21/2009 | US20090131489 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/21/2009 | US20090131482 Methyl-benzimidazole derivatives |
| 05/21/2009 | US20090131475 Compositions and methods for the treatment of metabolic disorders |
| 05/21/2009 | US20090131465 Synthesis and crystalline forms of melanocortin-4 receptor agonist |
| 05/21/2009 | US20090131464 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131451 Diagnosis and treatment of type 2 diabetes and other disorders |
| 05/21/2009 | US20090131450 Use of pkc inhibitors in diabetic complications |
| 05/21/2009 | US20090131447 Combination therapy |
| 05/21/2009 | US20090131434 such as E-4-[(2-methyl-2-{[4-(trifluoromethyl)benzyl]oxy}propanoyl)amino]adamantane-1-carboxamide, used for the treatment of non-insulin dependent diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, dementia, psychosis, depression or anxiety |
| 05/21/2009 | US20090131432 type II diabetes mellitus and obesity; dipeptidylpeptidase-IV (DPP-IV) inhibitor; 1-[2-(2-formylaminophenyl)-2-oxoethyl]-3-methyl-7-(3-methyl-2-buten-1-yl)-8-(3-aminopiperidin-1-yl)xanthine (xanthine=3,7-dihydro-purine-2,6-dione) |
| 05/21/2009 | US20090131429 Pharmaceutical compounds |
| 05/21/2009 | US20090131420 Novel Heterocyclic Analogs of Biphenyl Ethers |
| 05/21/2009 | US20090131418 Spiroazacyclic compounds as monoamine receptor modulators |
| 05/21/2009 | US20090131410 3-azabicyclooctane derivatives as muscarinic receptor antagonists |
| 05/21/2009 | US20090131409 1,4,5,6,7,8-HEXAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY |
| 05/21/2009 | US20090131404 Combinations |
| 05/21/2009 | US20090131402 Fused heterocyclic compound and use thereof |
| 05/21/2009 | US20090131398 Oxindole derivative as feeding control agent |
| 05/21/2009 | US20090131388 Agent for Improving Insulin Resistance |
| 05/21/2009 | US20090131387 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/21/2009 | US20090131374 Protein tyrosine phosphatase inhibitors and methods of use thereof |
| 05/21/2009 | US20090131372 Phosphonate analogs for treating metabolic diseases |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130225 Macrolides derivatives as antibacterial agents |
| 05/21/2009 | US20090130215 Granular preparation containing biguanide compound |
| 05/21/2009 | US20090130080 Reducing blood glucose level in a non-obese or obese human afflicted with Type 2 diabetes by administering purified human placental alkaline phosphatase |
| 05/21/2009 | US20090130075 Energy generating composition |
| 05/21/2009 | US20090130072 Use of Lactobacillus Kefiranofaciens as a Probiotic and a Synbiotic |
| 05/20/2009 | EP2060573A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 05/20/2009 | EP2060270A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 05/20/2009 | EP2060268A1 Pharmaceutical compositions for pulmonary or nasal delivery of peptides |
| 05/20/2009 | EP2060266A1 Y4 selective receptor agonists for therapeutic interventions |
| 05/20/2009 | EP2060263A1 Lipid-metabolism-ameliorating agent |
| 05/20/2009 | EP2059802A2 Methods for designing parp inhibitors and uses thereof |
| 05/20/2009 | EP2059522A2 Phosphonate and phosphinate compounds as glucokinase activators |
| 05/20/2009 | EP2059519A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/20/2009 | EP2059517A1 Pyrimidine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059516A1 Pyridine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059505A2 Muscarinic receptor antagonists |
| 05/20/2009 | EP2059242A1 Methods of lowering glucose levels |
| 05/20/2009 | EP2059241A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1354888B1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 05/20/2009 | EP1352638B1 Cosmetics for alleviating skin irritation |
| 05/20/2009 | EP0988274B1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE10248412B4 Suppositorium zur Behandlung oder Vorbeugung von Hypoglykämie Suppository for the treatment or prevention of hypoglycemia |
| 05/20/2009 | CN201241031Y System for manufacturing water milling powder made of bone |
| 05/20/2009 | CN201238665Y Medical therapy shoes |
| 05/20/2009 | CN101437942A Pharmaceutical compositions comprising anti-miRNA antisense oligonucleotides |
| 05/20/2009 | CN101437823A Polymorphs |
| 05/20/2009 | CN101437805A Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 05/20/2009 | CN101437804A Dibenzyl amine compounds and derivatives |
| 05/20/2009 | CN101437512A Glucokinase activators |
| 05/20/2009 | CN101437503A Compositions to reduce blood glucose levels and treat diabetes |
| 05/20/2009 | CN101437493A DPP IV inhibitor formulations |
| 05/20/2009 | CN101434660A Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination |
| 05/20/2009 | CN101434649A Small peptide, preparation thereof and use thereof in diagnosis or treatment of PACAP and VIP related diseases |
| 05/20/2009 | CN101434625A Anoectochilus roxburghii glycosides, derivatives thereof, preparation and use |
| 05/20/2009 | CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/20/2009 | CN101433667A Pharmaceutical composition with function for reducing blood sugar and preparation method thereof |
| 05/20/2009 | CN101433629A Chinese medicinal composition with function for reducing blood fat and preparation method thereof |
| 05/20/2009 | CN101433624A Lipid-lowering pressure-releasing hypoglycemic medicament and preparation method thereof |
| 05/20/2009 | CN101433622A Fumigation lotion for treating lower limb peripheral nerve pathological changes of diabetes patient |
| 05/20/2009 | CN101433607A Composition of Chinese medicine extract for treating diabetes |
| 05/20/2009 | CN101433597A Chinese medicinal composition with function for reducing blood sugar and preparation method thereof |
| 05/20/2009 | CN101433593A Compound Chinese medicine preparation for treating cardiovascular disease and preparation method thereof |
| 05/20/2009 | CN101433592A Lupulus extract containing xanthohumol and preparation method thereof |
| 05/20/2009 | CN101433581A Pharmaceutical composition |
| 05/20/2009 | CN101433578A Preparation of D-chiro-inositol in mungbean sprout |
| 05/20/2009 | CN101433573A Medicinal composition for treating diabetes |
| 05/20/2009 | CN101433567A Clinical novel use of soft capsule for removing thromboembolism |
| 05/20/2009 | CN101433536A Therapeutic compositions containing amlodipine niacin and losartan medicament |
| 05/20/2009 | CN101433534A Use of resveratrol dimer for preparing medicament for reducing blood sugar |
| 05/20/2009 | CN101433524A Glimepiride tablet and preparation method thereof |
| 05/20/2009 | CN101433356A Health-care beverage suitable for diabetes |
| 05/20/2009 | CN101433317A Fat-reducing health-care beverage |
| 05/20/2009 | CN101433295A Method for producing mungbean sprout suitable for diabetes to eat |
| 05/20/2009 | CN101433248A Method for making fat-eliminating and weight-losing tea |
| 05/20/2009 | CN101433246A Method for making beautification tea |
| 05/20/2009 | CN100488980C Integrin binding motif containing peptides and its uses |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488950C Use of chemotherapeutic agents |
| 05/20/2009 | CN100488546C Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method |